Navigation Links
FluoroPharma Announces $1.6M Capital Raise
Date:6/23/2011

an offer to buy the securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state. Any offering of the securities under the resale registration statement will only be by means of a prospectus.

Additional information about the capital raise transaction and FluoroPharma, can be found in FluoroPharma's Current Report on Form 8-K which will filed with the Securities and Exchange Commission.

About FluoroPharma Medical

FluoroPharma is a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to improve patient management by evaluating cardiac disease at the cellular and molecular levels. FluoroPharma is advancing two products in clinical trials for assessment of acute and chronic forms of coronary disease. These agents have been designed to rapidly target myocardial cells within the heart or inflamed plaques within the coronary arteries.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward looking statements in this news release include statements regarding FluoroPharma's research and development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as significant fluctuations in expenses associated with clinical trials, failure to secure additional financing, the inability to complete regulatory filings with the Food and Drug Administration, the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other informat
'/>"/>

SOURCE FluoroPharma Medical
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FluoroPharma Announces Completion of Merger and Fund Raising
2. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
3. FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
4. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
5. FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
6. Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information
7. Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX
8. ULURU Inc. Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor
9. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit
10. MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28
11. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Sinovac Biotech Ltd. (NASDAQ: SVA ... , today announced the results of the Company,s 2014 Annual ... Beijing , PRC. The required quorum, a majority ... The Company,s shareholders approved the following proposals:  , ... , Simon Anderson , Kenneth Lee and ...
(Date:8/27/2014)... , Aug. 27, 2014  AcelRx Pharmaceuticals, Inc. ... focused on the development and commercialization of innovative therapies ... announced that senior management will be participating at the ... the Morgan Stanley Global Healthcare Conference.  Details of the ... One on One Conference Date: Wednesday September 3 rd ...
(Date:8/26/2014)... KUALA LUMPUR, Malaysia , Aug. 27, 2014 ... penetration of health insurance are fuelling the demand ... . With the rise of medical tourism, the ... is further increasing. The market will continue its ... increasingly vulnerable to age-related and non-communicable diseases, compelling ...
Breaking Medicine Technology:Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 3Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 2Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 3Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 4
... HAYWARD, Calif., Dec. 14, 2010 Anthera Pharmaceuticals, Inc. ... drugs to treat serious diseases associated with abnormal auto-immune ... in the UK, to manufacture the large scale GMP ... peptibody in development for a number of autoimmune diseases. ...
... announces that a new market research report is available ... Global Markets http://www.reportlinker.com/p0341186/Antiemetics-Technologies-and-Global-Markets.html ... billion in 2009.  There was a little setback seen ... economy and competition within brands and generics.  The market ...
Cached Medicine Technology:Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Anthera's Investigational Novel Peptibody Agent 2Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Anthera's Investigational Novel Peptibody Agent 3Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Anthera's Investigational Novel Peptibody Agent 4Reportlinker Adds Antiemetics: Technologies and Global Markets 2Reportlinker Adds Antiemetics: Technologies and Global Markets 3Reportlinker Adds Antiemetics: Technologies and Global Markets 4Reportlinker Adds Antiemetics: Technologies and Global Markets 5Reportlinker Adds Antiemetics: Technologies and Global Markets 6Reportlinker Adds Antiemetics: Technologies and Global Markets 7Reportlinker Adds Antiemetics: Technologies and Global Markets 8Reportlinker Adds Antiemetics: Technologies and Global Markets 9Reportlinker Adds Antiemetics: Technologies and Global Markets 10Reportlinker Adds Antiemetics: Technologies and Global Markets 11Reportlinker Adds Antiemetics: Technologies and Global Markets 12Reportlinker Adds Antiemetics: Technologies and Global Markets 13
(Date:8/27/2014)... 27, 2014 Many patients believe mental ... that depression has a mortality rate of about 15%. ... is slightly less, though it's offset by an alarming ... In order to properly treat and manage symptoms of ... must be taken as directed. Missed dosages or ...
(Date:8/27/2014)... August 27, 2014 Beginning in September, ... Games (DOG) as an interactive, fun way for daycare ... free to all K9 Dog Park Doggy Daycare clients who ... days per week. Clients will be able to watch ... The dogs that compete in D.O.G. will win prizes ...
(Date:8/27/2014)... HealthDay Reporter TUESDAY, Aug. 26, ... need for blood transfusions might also protect the brains of ... which stimulates red blood cell production, appears to prevent brain ... Dr. Petra Huppi, a professor of pediatrics and newborn medicine ... test of whether EPO protects the brains of these children ...
(Date:8/27/2014)... eat over 10 portions a week of tomatoes have ... cancer, new research suggests. , With 35,000 new cases ... prostate cancer is the second most common cancer in ... which some experts believe is linked to a Westernised ... and lifestyle recommendations reduces risk of prostate cancer, researchers ...
(Date:8/27/2014)... 27, 2014 DISCcert has scheduled its ... place Sept 10th, 17th, 24th, and Oct 1st from ... receive a certification seal that will allow them to ... consists of four weekly one-hour webinar sessions. In between ... are offered individual coaching time. , Trainers, participating ...
Breaking Medicine News(10 mins):Health News:MedicationDiscountCard.com now Makes Brintellix and Mental Illness Medications More Affordable with Discount Cards 2Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 2Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 3Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 4Health News:Hormone Might Help Preemies' Brains 2Health News:Hormone Might Help Preemies' Brains 3Health News:Fighting prostate cancer with a tomato-rich diet 2Health News:Online DISC Certification Webinar Series to Begin Sept 10 Announces DISCcert 2Health News:Online DISC Certification Webinar Series to Begin Sept 10 Announces DISCcert 3Health News:Online DISC Certification Webinar Series to Begin Sept 10 Announces DISCcert 4
... Now in Winterizing their Animals and Homes, SACRAMENTO, ... are enough to shelter them from the cold. But ... be extremely,vulnerable in the winter months if they are ... and around their owners, homes.,Additionally, as pets vary in ...
... The patient he was,treating in the Yale University-affiliated ... Garth Graham thought he could almost be looking in ... and lived near,Graham,s own home in New Haven, Conn., ... contrast to Graham,s good health, the man was coughing,feverish, ...
... on seizures linked to lamotrigine use, research shows , ... levels of the drug lamotrigine in pregnant women with epilepsy ... research shows. , Lamotrigine, an epilepsy drug, is taken by ... of causing birth defects. However, the drug has also been ...
... whether magnesium sulfate can protect stroke victims, brains when ... is now expanding to include patients who cannot give ... in research studies is used in certain medical situations ... that occur suddenly and render the victim incapable of ...
... Candidates are Best for Working Families, FRESNO, Calif., ... Union have endorsed Councilman Henry T.,Perea for mayor of ... re-election, the union announced Thursday., The endorsements were ... members of SEIU locals 521, 1000, and United Healthcare ...
... 29 Today, "Keys to the Heart Meditation,",a ... LLC, for consumers,interested in the proven powers of ... a more peaceful, healthy life., (Photo: ... address recent studies showing an increase in,daily stress. ...
Cached Medicine News:Health News:Protect Pets From Winter's Hidden Dangers 2Health News:Protect Pets From Winter's Hidden Dangers 3Health News:Take the Test, Take Control: World AIDS Day 2007 2Health News:Tracking Drug Levels Helps Pregnant Women With Epilepsy 2Health News:Stroke study to add patients who cannot give immediate consent 2Health News:Stroke study to add patients who cannot give immediate consent 3Health News:SEIU Endorses Anderson, Perea, and Perea in Fresno 2Health News:New 'Keys to the Heart Meditation' CD Series Provides Sound Energy Therapy Using First Ever Recording of an Ancient Healing Instrument 2Health News:New 'Keys to the Heart Meditation' CD Series Provides Sound Energy Therapy Using First Ever Recording of an Ancient Healing Instrument 3
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Thermostatically controlled, large capacity surface to quickly evaporate water and solvents from slides and mounting media....
Liquichek Blood Gas Plus CO-Oximeter Control (IL Synthesis Series) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximetry anal...
Medicine Products: